Search
Search Results
##search.searchResults.foundPlural##
-
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4184PDF: 1617HTML: 9317Untitled: 327Untitled: 229Untitled: 212Untitled: 213Untitled: 227Untitled: 379 -
Anemia in the elderly: not always what it seems.
3427PDF: 1145HTML: 1809Figure 1: 233Figure 1 revised: 251 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4468PDF: 1264HTML: 2429Figure 1: 220 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3233PDF: 952HTML: 7316Kost Fig1: 230Kost Fig 2: 217Kost Fig3: 230Kost Fig 4: 242Kost Fig5: 237Kost fig 6: 226 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2811PDF: 827HTML: 2333 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1587PDF: 970Suppl. Files: 491HTML: 303 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
4203PDF: 1176HTML: 921 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
3032PDF: 1350HTML: 2843Figure 1: 221 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2522PDF: 1275HTML: 3908 -
AGING WITH THALASSEMIA AND SICKLE CELL DISEASE: A GERONTOLOGICAL MODEL OF ACCELERATED MULTIMORBIDITY AND FUNCTION-CENTERED CARE BEYOND MIDLIFE Thalassemia and Sickle Cell Diseases: Effect of Aging
593PDF: 611Suppl. Files: 80HTML: 168 -
Magnusiomyces capitatus Breakthrough Infection in Allogeneic Hematopoietic Cell Transplant Recipients Receiving Echinocandin Prophylaxis: Clinical Features, Management, and Review of the Literature
102PDF: 161Suppl. Files: 20Html: 106Html Suppl. Files: 80 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2318PDF: 1050HTML: 1991 -
Pathologic splenic rupture in a patient with follicular lymphoma
1501PDF: 609HTML: 1230rupture: 222 -
CD56+/CD38+ Neutrophils: Rapid and Specific Flow Cytometric Signature for Chronic Myeloid Leukemia
352PDF: 345Suppl. Files: 77HTML: 75 -
IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES
1878PDF: 997HTML: 1202Untitled: 204Untitled: 226Untitled: 211Untitled: 200 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3413PDF: 1105HTML: 2504 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
5111PDF: 2974HTML: 2363 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
2149PDF: 934HTML: 1108 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3820PDF: 1774HTML: 2743 -
NURSES’ PHYSICAL AND PSYCHOLOGICAL SYMPTOMS DURING THE FIRST COVID-19 LOCKDOWN IN ITALY A nationwide cross-sectional study in stem cell transplantation setting.
2274PDF: 907HTML: 384 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3516PDF: 2084HTML: 7583 -
A case of iron deficiency anemia with co-existing Hb Fontainebleau.
1501PDF: 815HTML: 2104Untitled: 343 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1671PDF: 1180HTML: 273







